Summit Global Investments Surface Oncology, Inc. Transaction History

Summit Global Investments

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.73 - $7.9 $267,476 - $446,737	-56,549 Closed	0 $0
Q3 2021 Nov 08, 2021	BUY	$5.16 - $7.98 $200,724 - $310,422	38,900 Added 220.41%	56,549 $428,000
Q2 2021 Jan 28, 2022	SELL	$6.45 - $9.09 $143,190 - $201,798	-22,200 Reduced 55.71%	17,649 $132,000
Q1 2021 Jan 27, 2022	BUY	$7.25 - $13.82 $288,905 - $550,713	39,849 New	39,849 $311,000

315K

Ticker SURF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,034,000
Description
Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibo...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.